VKH
GENE

Virtu KCG Holdings’s Genetic Technologies Ltd. GENE Stock Holding History

Virtu KCG Holdings’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$77K Buy
+4,298
New +$90K ﹤0.01% 2486
2016
Q4 		– Sell
-681
Closed -$24K – 3885
2016
Q3 		$24K Sell
681
-51
-7% -$2.08K ﹤0.01% 2905
2016
Q2 		$31K Buy
732
+43
+6% +$1.98K ﹤0.01% 2745
2016
Q1 		$32K Buy
+689
New +$30K ﹤0.01% 2536
2015
Q4 		– Sell
-1,127
Closed -$40K – 4028
2015
Q3 		$40K Sell
1,127
-4,190
-79% -$225K ﹤0.01% 3042
2015
Q2 		$323K Buy
5,317
+4,751
+839% +$398K 0.01% 1973
2015
Q1 		$60K Buy
566
+369
+187% +$30.2K ﹤0.01% 2791
2014
Q4 		$8K Sell
197
-540
-73% -$21.6K ﹤0.01% 3667
2014
Q3 		$42K Buy
737
+483
+190% +$37.7K ﹤0.01% 3379
2014
Q2 		$27K Sell
254
-355
-58% -$42.4K ﹤0.01% 3502
2014
Q1 		$85K Buy
609
+397
+187% +$63.5K ﹤0.01% 3244
2013
Q4 		$31K Buy
212
+104
+96% +$19.3K ﹤0.01% 3676
2013
Q3 		$25K Buy
+108
New +$25.7K ﹤0.01% 3598

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Virtu KCG Holdings's GENE Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Genetic Technologies Ltd. (GENE) in Q2 2017: 4,298 shares worth $77K. The stake represents ﹤0.01% of the portfolio and ranks #2486 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in GENE as recently as Q3 2016.

Virtu KCG Holdings first reported a position in GENE in Q3 2013 and has held it in 13 quarters since. The position peaked at $323K in Q2 2015. 17 funds tracked by Wall St. Rank hold GENE as of Q2 2017.

  • Virtu KCG Holdings held 4,298 shares of Genetic Technologies Ltd. worth $77K as of Q2 2017.
  • Genetic Technologies Ltd. was a new Virtu KCG Holdings position in Q2 2017.
  • Genetic Technologies Ltd. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2486 holding.
  • Virtu KCG Holdings first reported a position in Genetic Technologies Ltd. in Q3 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's Genetic Technologies Ltd. position peaked at $323K in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.